Concepedia

Joseph Quinn

JQ

Statistics

Publications

10

Citations

1.5K

H-Index

10

Active since

1995

Affiliations

University of North Carolina at Chapel Hill(Current)

AIDS Clinical Trials Group

University of Pennsylvania

University of Colorado Health

Social and Scientific Systems (United States)

Joseph Quinn is an author at University of North Carolina at Chapel Hill specializing in antiretroviral therapy, clinical pharmacology, and pharmacology.

Publications per year

1995–2021

10

Publications

10

Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

Joseph J. Eron, Sharon L. Benoit, Joseph G. Jemsek et al. · New England Journal of Medicine · 1995 · 538 citations · Full text

, , +17

Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects

Ian Sanne, Herve Momméja-Marin, John E. Hinkle et al. · The Journal of Infectious Diseases · 2005 · 242 citations · Full text

, , +16

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients

Daniel R. Kuritzkes, Joseph Quinn, Sharon L. Benoit et al. · AIDS · 1996 · 179 citations

, , +17

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

Pablo Tebas, Ian Frank, Mark G. Lewis et al. · AIDS · 2010 · 145 citations

, , +17

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 138 citations · Full text

, , +4

1–5 of 10